Approval · Notice of Compliance 11352 · 2010
ONSOLIS: Notice of Compliance 11352
Issued May 5, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11352
- Date
- May 5, 2010
- Company
- Meda AbSolna, --, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- FENTANYL CITRATE 200 MCG per UNIT
- FENTANYL CITRATE 400 MCG per UNIT
- FENTANYL CITRATE 600 MCG per UNIT
- FENTANYL CITRATE 800 MCG per UNIT
- FENTANYL CITRATE 1,200 MCG per UNIT